159 related articles for article (PubMed ID: 6331166)
1. Cost implications of routine antenatal administration of Rh immune globulin.
Adams MM; Marks JS; Koplan JP
Am J Obstet Gynecol; 1984 Jul; 149(6):633-8. PubMed ID: 6331166
[TBL] [Abstract][Full Text] [Related]
2. Antepartum Rh immune globulin.
Wible-Kant J; Beer AE
Clin Perinatol; 1983 Jun; 10(2):343-55. PubMed ID: 6311476
[TBL] [Abstract][Full Text] [Related]
3. Preventing rhesus isoimmunization. Antepartum Rh immune globulin prophylaxis versus a sensitive test for risk identification.
Hensleigh PA
Am J Obstet Gynecol; 1983 Aug; 146(7):749-55. PubMed ID: 6307052
[TBL] [Abstract][Full Text] [Related]
4. Antenatal anti-D immunoglobulin.
Lancet; 1983 Sep; 2(8352):734. PubMed ID: 6136859
[No Abstract] [Full Text] [Related]
5. The experience and effectiveness of the Nova Scotia Rh program, 1964-84.
Baskett TF; Parsons ML; Peddle LJ
CMAJ; 1986 Jun; 134(11):1259-61. PubMed ID: 3011235
[TBL] [Abstract][Full Text] [Related]
6. Serum sickness due to Rh(anti-D) immunoglobulin.
Jones BF; Trevillian PR; Nanra RS
Aust N Z J Obstet Gynaecol; 1984 Feb; 24(1):49-50. PubMed ID: 6331369
[TBL] [Abstract][Full Text] [Related]
7. Utilization of Rh prophylaxis.
Berger GS; Keith L
Clin Obstet Gynecol; 1982 Jun; 25(2):267-75. PubMed ID: 6179676
[TBL] [Abstract][Full Text] [Related]
8. Rh hemolytic disease. Epidemiologic surveillance in the United States, 1968 to 1975.
Wysowski DK; Flynt JW; Goldberg MF; Connell FA
JAMA; 1979 Sep; 242(13):1376-9. PubMed ID: 113567
[TBL] [Abstract][Full Text] [Related]
9. Prevention of Rh hemolytic disease--ten years' clinical experience with Rh immune globulin.
Freda VJ; Gorman JG; Pollack W; Bowe E
N Engl J Med; 1975 May; 292(19):1014-6. PubMed ID: 804134
[TBL] [Abstract][Full Text] [Related]
10. Rh immune globulin after genetic amniocentesis: impact on pregnancy outcome.
Crane JP; Rohland B; Larson D
Am J Med Genet; 1984 Dec; 19(4):763-8. PubMed ID: 6097129
[TBL] [Abstract][Full Text] [Related]
11. The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae.
Tovey LA; Townley A; Stevenson BJ; Taverner J
Lancet; 1983 Jul; 2(8344):244-6. PubMed ID: 6135077
[TBL] [Abstract][Full Text] [Related]
12. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Rh hemolytic disease of the newborn, United States, 1960-1979.
Adams MM; Gustafson J
Prog Clin Biol Res; 1981; 70():213-7. PubMed ID: 6273934
[No Abstract] [Full Text] [Related]
14. Rh negative status and isoimmunization update: a case-based approach to care.
Harrod KS; Hanson L; VandeVusse L; Heywood P
J Perinat Neonatal Nurs; 2003; 17(3):166-78; quiz 179-80. PubMed ID: 12959478
[TBL] [Abstract][Full Text] [Related]
15. Efforts should be made to eradicate Rh hemolytic disease of the fetus and newborn.
Caiola G
Obstet Gynecol Surv; 1984 Jan; 39(1):55-7. PubMed ID: 6320075
[No Abstract] [Full Text] [Related]
16. Controversies in Rh prophylaxis. Who needs Rh immune globulin and when should it be given?
Bowman JM
Am J Obstet Gynecol; 1985 Feb; 151(3):289-94. PubMed ID: 2982267
[TBL] [Abstract][Full Text] [Related]
17. Costs and benefits of non-invasive fetal RhD determination.
Teitelbaum L; Metcalfe A; Clarke G; Parboosingh JS; Wilson RD; Johnson JM
Ultrasound Obstet Gynecol; 2015 Jan; 45(1):84-8. PubMed ID: 25380024
[TBL] [Abstract][Full Text] [Related]
18. A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative.
Chilcott J; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C; Tappenden P
Health Technol Assess; 2003; 7(4):iii-62. PubMed ID: 12633527
[No Abstract] [Full Text] [Related]
19. [Evaluation of the Center for Rh-negative Mothers. Hospital Paula Jaraquemada (3 years)].
Krug A; Bianchi R; Pérez N; Ilabaca G; Farías S; Rojas E
Rev Chil Obstet Ginecol; 1981; 46(4):206-14. PubMed ID: 6099901
[No Abstract] [Full Text] [Related]
20. Rh disease: how near the end?
Freda VJ; Pollack W; Gorman JG
Hosp Pract; 1978 Jun; 13(6):61-9. PubMed ID: 99361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
